CHAPTER 21 Use of Nutraceuticals for Equine Joint Disease
Joint supplements (nutraceuticals) have been the focus of much debate in both the human and veterinary literature, and confusion exists regarding product selection, specific application, and expected efficacy. These agents are thought to prevent or slow the progressive deterioration of articular cartilage by (1) counteracting inflammation, (2) reducing articular cartilage degradation, and (3) stimulating cartilage synthesis.
LICENSING AND PROOF OF EFFICACY
None of the oral supplements or oral nutraceuticals is licensed by the FDA, and proof of efficacy is generally lacking. Most products contain glucosamine or chondroitin sulfate or both, along with other added ingredients. Historically, the oral glycosaminoglycan products that were initially available for the horse included a chondroitin sulfate product from bovine trachea and a complex of glycosaminoglycans and other nutrients from the sea mussel Perna canaliculus. A combination of glucosamine hydrochloride (glucosamine), chondroitin sulfate, manganese, and vitamin C has been marketed as a nutraceutical,∗ and a number of other products have simulated this product. Since that time, other products have attempted to compete on the basis of decreased cost (with no demonstration of comparable efficacy) or other added ingredients.